Glen Eagle Advisors’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$944 Buy
+15
New +$1.05K ﹤0.01% 990
2023
Q1
Sell
-12
Closed -$876 1173
2022
Q4
$876 Buy
+12
New +$948 ﹤0.01% 1033
2022
Q2
Sell
-6
Closed -$621 1019
2022
Q1
$621 Hold
6
﹤0.01% 894
2021
Q4
$452 Buy
+6
New +$420 ﹤0.01% 893
2021
Q3
Sell
-30
Closed -$1.82K 1084
2021
Q2
$1.82K Hold
30
﹤0.01% 926
2021
Q1
$1.62K Hold
30
﹤0.01% 903
2020
Q4
$1.44K Hold
30
﹤0.01% 880
2020
Q3
$1.17K Hold
30
﹤0.01% 836
2020
Q2
$961 Hold
30
﹤0.01% 818
2020
Q1
$1.01K Hold
30
﹤0.01% 752
2019
Q4
$1.44K Hold
30
﹤0.01% 807
2019
Q3
$1.5K Hold
30
﹤0.01% 732
2019
Q2
$1.61K Hold
30
﹤0.01% 712
2019
Q1
$1.58K Buy
30
+9
+43% +$469 ﹤0.01% 671
2018
Q4
$986 Hold
21
﹤0.01% 673
2018
Q3
$1.21K Buy
+21
New +$1.16K ﹤0.01% 661

Other funds holding NTR

Glen Eagle Advisors's NTR Position: Q2 2026 in Review

Glen Eagle Advisors opened a new position in Nutrien (NTR) in Q2 2026: 15 shares worth $944. The stake represents ﹤0.01% of the portfolio and ranks #990 among its holdings. This is a return to the name: Glen Eagle Advisors previously reported a position in NTR as recently as Q4 2022.

Glen Eagle Advisors first reported a position in NTR in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.82K in Q2 2021. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Glen Eagle Advisors held 15 shares of Nutrien worth $944 as of Q2 2026.
  • Nutrien was a new Glen Eagle Advisors position in Q2 2026.
  • Nutrien made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #990 holding.
  • Glen Eagle Advisors first reported a position in Nutrien in Q3 2018 and has held it in 16 quarters since.
  • Glen Eagle Advisors's Nutrien position peaked at $1.82K in Q2 2021.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.